OCS Liver PROTECT Continuation Post-Approval Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05096741

Enrollment

300

Registered

2021-10-27

Start date

2016-01-24

Completion date

2021-11-05

Last updated

2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant

Brief summary

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.

Detailed description

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT Trial.

Interventions

DEVICEOCS Liver

Transplanted with a OCS preserved liver

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subjects transplanted in the OCS Liver PROTECT Trial

Design outcomes

Primary

Measure	Time frame	Description
Liver Graft Survival	2 years	Liver Graft Survival through 2 years (24 months) after transplantation.

Other

Measure	Time frame	Description
Patient Survival	2 years	Patient Survival (freedom from mortality) through 2 years (24 months) after transplantation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026